Finorify

NAMS

NewAmsterdam Pharma Company

$31.14-2.63%

Price

NAMS daily closing price
Market cap
$3.64 billion
Volume
872.5K
Sector
Healthcare

NewAmsterdam Pharma Company (NAMS) last closed at $31.14, on a daily price path from October 21, 2025 to October 21, 2026. Overview is that price path. Performance is the change in the close over the periods Finorify shows on the stock screen. Financials, cash flow, and margins come from reported quarters. Valuation lists the latest ratios. This snapshot is the Finorify stock screen for NAMS, covered for search and blurred for visitors.

Performance

  • 1D-0.05%
  • 5D+7.40%
  • 1M-7.85%
  • 3M-29.66%
  • 6M-32.72%
  • 1Y-42.94%
  • 5Y+119.29%

Financials

NAMS revenueQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Over the latest four reported periods ending June 30, 2026, NewAmsterdam Pharma Company reported revenue of $7.1 million.

The prior window totaled $64 million, so the latest window is lower than that stretch.

Operating cash flow in the latest window was -$143.5 million.

Free cash flow in the latest window was -$143.7 million.

These amounts are taken from NewAmsterdam Pharma Company's SEC filings and are a snapshot as of August 14, 2026. They are not a live price, and they are not a recommendation to buy or sell. Finorify uses the same filings to draw the charts inside the app.

A few ratios from those statements: Profitability: ROE -10.2% (0 of 100). Cash generation: FCF margin -2018.3% (0 of 100). Net margin: -1732.9% (0 of 100). Liquidity: Current 9.03× (100 of 100).

Cash Flow

NAMS free cash flowQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Margins

NAMS operating margin

Valuation

P/S (TTM)
539

Insights

Finorify has not written notes for NAMS in this snapshot.

Read the live analysis in Finorify

Charts, news, and the written notes are in the app. You can open five distinct stocks free. After that, the stock screen is a Finorify Pro feature.

Open NAMS in Finorify